0001209191-15-069484.txt : 20150903 0001209191-15-069484.hdr.sgml : 20150903 20150903171708 ACCESSION NUMBER: 0001209191-15-069484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150901 FILED AS OF DATE: 20150903 DATE AS OF CHANGE: 20150903 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001373707 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617.715.3600 MAIL ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Macdonald Guy CENTRAL INDEX KEY: 0001296998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35837 FILM NUMBER: 151092741 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-01 0 0001373707 TETRAPHASE PHARMACEUTICALS INC TTPH 0001296998 Macdonald Guy 480 ARSENAL ST. SUITE 110 WATERTOWN MA 02472 1 1 0 0 President and Chief Executive Common Stock 2015-09-01 4 M 0 10000 7.94 A 62000 D Common Stock 2015-09-01 4 S 0 10000 41.57 D 52000 D Employee Stock Option (right to buy) 7.94 2015-09-01 4 M 0 10000 0.00 D 2023-05-14 Common Stock 10000 180000 D The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $40.51 to $43.34 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Vests as to 25% of the original number of shares granted on 5/15/2014 and further vests as to an additional 6.25% of the original number of shares granted at the end of each successive three-month period thereafter until 5/15/2017. /s/Maria Stahl as Attorney-in-Fact for Guy Macdonald 2015-09-03